lupus erythematosus

Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programme
Toni Maslen, Ian N Bruce, David D'Cruz, Mihaela Ianosev, Damon L Bass, Christel Wilkinson, David A Roth

Lupus Science & Medicine Feb 2021, 8 (1) e000459; DOI: 10.1136/lupus-2020-000459
What are the topics you care about making trials in lupus more effective? Results of an Open Space meeting of international lupus experts
Johanna Mucke, Marta Alarcon-Riquelme, Jeanette Andersen, Martin Aringer, Stefano Bombardieri, Ralph Brinks, Ricard Cervera, Gamal Chehab, Alain Cornet, Nathalie Costedoat-Chalumeau, László Czirják, Andrea Doria, Rebecca Fischer-Betz, Richard A Furie, Mariele Gatto, Frédéric A Houssiau, Luis Ines, Matthew H Liang, Eric Morand, Marta Mosca, José María Pego-Reigosa, Iñigo Rúa-Figueroa, Guillermo Ruiz-Irastorza, Benjamin Terrier, Anne Voss, Matthias Schneider

Lupus Science & Medicine May 2021, 8 (1) e000506; DOI: 10.1136/lupus-2021-000506
Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004–2015
Edward R Hammond, Barnabas Desta, Aimee M Near, Xia Wang, Miao Jiang

Lupus Science & Medicine Sep 2021, 8 (1) e000504; DOI: 10.1136/lupus-2021-000504
Assessment of SLE activity for acute clinical decision-making: use of a colour-coded threat-level approach for the non-rheumatologist
Cindy Flower

Lupus Science & Medicine Feb 2021, 8 (1) e000484; DOI: 10.1136/lupus-2021-000484
Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus
Jagan Sivakumaran, Paula Harvey, Ahmed Omar, Oshrat Tayer-Shifman, Murray B Urowitz, Dafna D Gladman, Nicole Anderson, Jiandong Su, Zahi Touma

Lupus Science & Medicine May 2021, 8 (1) e000448; DOI: 10.1136/lupus-2020-000448
ANA-positive primary immune thrombocytopaenia: a different clinical entity with increased risk of connective tissue diseases
Yuan Liu, Shiju Chen, Guomei Yang, Bin Wang, Jinying Lan, Fan Dai, Peishi Rao, Puqi Wu, Hongyan Qian, Guixiu Shi

Lupus Science & Medicine Oct 2021, 8 (1) e000523; DOI: 10.1136/lupus-2021-000523
Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials
Raj Tummala, Gabriel Abreu, Lilia Pineda, M Alex Michaels, Rubana N Kalyani, Richard A Furie, Eric F Morand

Lupus Science & Medicine Feb 2021, 8 (1) e000464; DOI: 10.1136/lupus-2020-000464
Use of a screening questionnaire for systemic lupus erythematosus among pregnant women in a Mexican population
Luis Lucero-Morales, Juanita Romero-Diaz, Diana Yazmin Copado-Mendoza, María del Carmen Zamora-Medina, Sandra Acevedo-Gallegos, Juan Manuel Gallardo-Gaona, Berenice Velazquez-Torres, Jose Antonio Ramirez-Calvo, Dulce Maria Camarena-Cabrera, Maria Jose Rodriguez-Sibaja

Lupus Science & Medicine Jun 2021, 8 (1) e000486; DOI: 10.1136/lupus-2021-000486
Hospitalisation for systemic lupus erythematosus associates with an increased risk of mortality in Australian patients from 1980 to 2014: a longitudinal, population-level, data linkage, cohort study
Warren David Raymond, Susan Lester, David Brian Preen, Helen Isobel Keen, Charles Anoopkumar Inderjeeth, Michael Furfaro, Johannes Cornelis Nossent

Lupus Science & Medicine Oct 2021, 8 (1) e000539; DOI: 10.1136/lupus-2021-000539
RNA tape sampling in cutaneous lupus erythematosus discriminates affected from unaffected and healthy volunteer skin
Joseph F Merola, Wenting Wang, Carrie G Wager, Stefan Hamann, Xueli Zhang, Alice Thai, Christopher Roberts, Christina Lam, Cristina Musselli, Galina Marsh, Dania Rabah, Catherine Barbey, Nathalie Franchimont, Taylor L Reynolds

Lupus Science & Medicine Mar 2021, 8 (1) e000428; DOI: 10.1136/lupus-2020-000428

Main menu

lupus erythematosus

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

lupus erythematosus

Pages